SubHero Banner
Text

December 2022

Core topics in this month’s edition include:

  • Adstiladrin (nadofaragene firadenovec-vncg) - new gene therapy approval
  • Lunsumio (mosunetuzumab-axgb) - new drug approval
  • Sunlenca (lenacapavir) - new drug approval

Download PDF

Text